Mr. Voll will lead a finance team that will continue to include Ronald B. Kocak (who until Mr. Voll’s appointment served as principal accounting officer of RenovoRx) for a transitional period as well ...
RenovoRx, Inc. ("RenovoRx" or "the Company") (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果